Plexxikon
Trending Articles
Related Content
Research & Development
PhoreMost and Plexxikon collaborate to identify novel drug targets
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, has signed a collaborative agreement with Plexxikon, the small molecule structure-guided R&D centre of Daiichi Sankyo.